Pfizer CEO Albert Bourla said on Tuesday that he believes it is 'likely' that a strain of COVID-19 could emerge that is resistant to vaccines.
However, the pharmaceuticals boss claimed that the company would be able to develop a new shot to tackle a vaccine-resistant strain within 95 days of its emergence, Fox News reported.
'Every time that a variant appears in the world, our scientists are getting their hands around it,' Bourla said.
'And they are researching to see if this variant can escape the protection of our vaccine. We haven't identified any yet, but we believe that it is likely that one day, one of them will emerge.'
He added: 'We have built a process that within 95 days from the day that we identify a variant as a variant of concern, we will be able to have a vaccine tailor-made against this variant.'
In July, Rochelle Walensky – director of the Centers for Disease Control and Prevention – warned that the coronavirus could mutate and potentially evade vaccines soon.
So-called breakthrough infections among people who've had Pfizer's vaccine – as well as shots from Moderna and Johnson & Johnson have occurred – although they rarely result in serious illness.
However, a virologist at the University of Saskatchewan in Canada told The Telegraph that it was unlikely that the coronavirus could mutate into a vaccine-resistant strain.
'It would require so many mutations in the spike protein that this virus wouldn't 'work' anymore,' Angela Rasmussen said.
Other experts recently blasted a 'fear-mongering' article warning of a 'doomsday' COVID-19 variant which could be worse than Delta.
The doctors emphasized the effectiveness of the jab against the virus and noted that vaccine makers can quickly adjust formulas to make vaccines more effective against variants, Fox News reported.
Their comments come in response to an article in Newsweek Magazine which claimed that the Delta variant has 'shattered' optimism that vaccines would help the pandemic wind down.
The Newsweek Magazine article questioned: 'Is there a Doomsday variant out there that shrugs off vaccines, spreads like wildfire and leaves more of its victims much sicker than anything we've yet seen?'
'The odds are not high that we will see such a triple threat, but experts can't rule it out,' the article reads.
The Newsweek Magazine article appears to draw a number of conclusions, including that the pandemic will continue to get worse and may stick around 'forevermore' – while continuing to mutate.
'The next variant could be Delta on steroids,' warned Michael Osterholm, an epidemiologist.
Osterholm, who leads the Center for Infectious Disease Research and Policy at the University of Minnesota, added that – because of the Delta variant – 'the number of intensive-care beds needed could be higher than any time we've seen.'
He said that an analysis from his team shows that every American who has not been vaccinated or had the disease yet, about 100 million people, will likely get it in the coming months.
News
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]















